A disintegrin and metallopeptidase domain (ADAM) 12, ADAM 17 mRNA and ADAM10 protein hold potential as biomarkers for detection of early gastric cancer

Abstract No biomarker can effectively screen for early gastric cancer (EGC). Players in the A disintegrin and metalloproteinase (ADAM)-natural killer group 2 member D (NKG2D) receptor axis may have a role for that. As a proof-of-concept pilot study, the expression of ADAM8, ADAM9, ADAM10, ADAM12, AD...

Full description

Saved in:
Bibliographic Details
Main Authors: Sooyeon Oh, Sang-Soo Lee, Hoeyoung Jin, Seo-Hyeon Choi, Choong-Keun Cha, Jooho Lee, KyuBum Kwack, Sang Gyun Kim, Sang-Woon Choi
Format: Article
Language:English
Published: Nature Portfolio 2025-01-01
Series:Scientific Reports
Subjects:
Online Access:https://doi.org/10.1038/s41598-024-84237-y
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1841559631866888192
author Sooyeon Oh
Sang-Soo Lee
Hoeyoung Jin
Seo-Hyeon Choi
Choong-Keun Cha
Jooho Lee
KyuBum Kwack
Sang Gyun Kim
Sang-Woon Choi
author_facet Sooyeon Oh
Sang-Soo Lee
Hoeyoung Jin
Seo-Hyeon Choi
Choong-Keun Cha
Jooho Lee
KyuBum Kwack
Sang Gyun Kim
Sang-Woon Choi
author_sort Sooyeon Oh
collection DOAJ
description Abstract No biomarker can effectively screen for early gastric cancer (EGC). Players in the A disintegrin and metalloproteinase (ADAM)-natural killer group 2 member D (NKG2D) receptor axis may have a role for that. As a proof-of-concept pilot study, the expression of ADAM8, ADAM9, ADAM10, ADAM12, ADAM17, and major histocompatibility complex (MHC) class I chain-related sequence A (MICA), a ligand for NKG2D, in gastric cancer was investigated in silico using The Cancer Genome Atlas (TCGA) database. Subsequently, the mRNA and protein expression levels of these markers except ADAM8 were tested in blood samples from patients with EGC and healthy controls. In the TCGA data analyses, EGC tissues (n = 57) expressed significantly higher mRNA levels of ADAM8, ADAM9, ADAM10, ADAM12, and ADAM17 than normal tissues (n = 35) (p < 0.005). In human blood sample analyses, ADAM12 (p = 0.0007), ADAM17 mRNA (p < 0.0001) and ADAM10 (p < 0.0017) protein were significantly elevated in patients with EGC (n = 27 for mRNA and n = 25 for protein) compared to the controls (n = 30 for mRNA and n = 26 for protein). Areas under the curves calculated by receiver-operating characteristic analysis for ADAM12, ADAM17 mRNA and ADAM10 protein were 0.7568 (95% confidence interval [CI]: 0.6334 to 0.8802), 0.8062 (95% CI: 0.6889 to 0.9234; p < 0.0001), and 0.8108 (95% CI: 0.6895 to 0.9320; p = 0.0001), respectively. Thus, ADAM12, ADAM17 mRNA and ADAM10 protein levels in peripheral blood could hold potential as biomarkers for screening EGC, and further investigations are required.
format Article
id doaj-art-fd75795a84d04d32b8dc862d829ab24e
institution Kabale University
issn 2045-2322
language English
publishDate 2025-01-01
publisher Nature Portfolio
record_format Article
series Scientific Reports
spelling doaj-art-fd75795a84d04d32b8dc862d829ab24e2025-01-05T12:21:15ZengNature PortfolioScientific Reports2045-23222025-01-0115111210.1038/s41598-024-84237-yA disintegrin and metallopeptidase domain (ADAM) 12, ADAM 17 mRNA and ADAM10 protein hold potential as biomarkers for detection of early gastric cancerSooyeon Oh0Sang-Soo Lee1Hoeyoung Jin2Seo-Hyeon Choi3Choong-Keun Cha4Jooho Lee5KyuBum Kwack6Sang Gyun Kim7Sang-Woon Choi8Chaum Life Center, CHA University School of MedicineDepartment of Biomedical Science, College of Life Science, CHA UniversityDepartment of Biomedical Science, College of Life Science, CHA UniversityDepartment of Biomedical Science, College of Life Science, CHA UniversityChaum Life Center, CHA University School of MedicineDepartment of Gastroenterology and Hepatology, CHA Bundang Medical Center, CHA University School of MedicineDepartment of Biomedical Science, College of Life Science, CHA UniversityDivision of Gastroenterology, Department of Internal Medicine and Liver Research Institute, Seoul National University College of MedicineChaum Life Center, CHA University School of MedicineAbstract No biomarker can effectively screen for early gastric cancer (EGC). Players in the A disintegrin and metalloproteinase (ADAM)-natural killer group 2 member D (NKG2D) receptor axis may have a role for that. As a proof-of-concept pilot study, the expression of ADAM8, ADAM9, ADAM10, ADAM12, ADAM17, and major histocompatibility complex (MHC) class I chain-related sequence A (MICA), a ligand for NKG2D, in gastric cancer was investigated in silico using The Cancer Genome Atlas (TCGA) database. Subsequently, the mRNA and protein expression levels of these markers except ADAM8 were tested in blood samples from patients with EGC and healthy controls. In the TCGA data analyses, EGC tissues (n = 57) expressed significantly higher mRNA levels of ADAM8, ADAM9, ADAM10, ADAM12, and ADAM17 than normal tissues (n = 35) (p < 0.005). In human blood sample analyses, ADAM12 (p = 0.0007), ADAM17 mRNA (p < 0.0001) and ADAM10 (p < 0.0017) protein were significantly elevated in patients with EGC (n = 27 for mRNA and n = 25 for protein) compared to the controls (n = 30 for mRNA and n = 26 for protein). Areas under the curves calculated by receiver-operating characteristic analysis for ADAM12, ADAM17 mRNA and ADAM10 protein were 0.7568 (95% confidence interval [CI]: 0.6334 to 0.8802), 0.8062 (95% CI: 0.6889 to 0.9234; p < 0.0001), and 0.8108 (95% CI: 0.6895 to 0.9320; p = 0.0001), respectively. Thus, ADAM12, ADAM17 mRNA and ADAM10 protein levels in peripheral blood could hold potential as biomarkers for screening EGC, and further investigations are required.https://doi.org/10.1038/s41598-024-84237-yADAM12ADAM17ADAM10Gastric cancerBiomarker
spellingShingle Sooyeon Oh
Sang-Soo Lee
Hoeyoung Jin
Seo-Hyeon Choi
Choong-Keun Cha
Jooho Lee
KyuBum Kwack
Sang Gyun Kim
Sang-Woon Choi
A disintegrin and metallopeptidase domain (ADAM) 12, ADAM 17 mRNA and ADAM10 protein hold potential as biomarkers for detection of early gastric cancer
Scientific Reports
ADAM12
ADAM17
ADAM10
Gastric cancer
Biomarker
title A disintegrin and metallopeptidase domain (ADAM) 12, ADAM 17 mRNA and ADAM10 protein hold potential as biomarkers for detection of early gastric cancer
title_full A disintegrin and metallopeptidase domain (ADAM) 12, ADAM 17 mRNA and ADAM10 protein hold potential as biomarkers for detection of early gastric cancer
title_fullStr A disintegrin and metallopeptidase domain (ADAM) 12, ADAM 17 mRNA and ADAM10 protein hold potential as biomarkers for detection of early gastric cancer
title_full_unstemmed A disintegrin and metallopeptidase domain (ADAM) 12, ADAM 17 mRNA and ADAM10 protein hold potential as biomarkers for detection of early gastric cancer
title_short A disintegrin and metallopeptidase domain (ADAM) 12, ADAM 17 mRNA and ADAM10 protein hold potential as biomarkers for detection of early gastric cancer
title_sort disintegrin and metallopeptidase domain adam 12 adam 17 mrna and adam10 protein hold potential as biomarkers for detection of early gastric cancer
topic ADAM12
ADAM17
ADAM10
Gastric cancer
Biomarker
url https://doi.org/10.1038/s41598-024-84237-y
work_keys_str_mv AT sooyeonoh adisintegrinandmetallopeptidasedomainadam12adam17mrnaandadam10proteinholdpotentialasbiomarkersfordetectionofearlygastriccancer
AT sangsoolee adisintegrinandmetallopeptidasedomainadam12adam17mrnaandadam10proteinholdpotentialasbiomarkersfordetectionofearlygastriccancer
AT hoeyoungjin adisintegrinandmetallopeptidasedomainadam12adam17mrnaandadam10proteinholdpotentialasbiomarkersfordetectionofearlygastriccancer
AT seohyeonchoi adisintegrinandmetallopeptidasedomainadam12adam17mrnaandadam10proteinholdpotentialasbiomarkersfordetectionofearlygastriccancer
AT choongkeuncha adisintegrinandmetallopeptidasedomainadam12adam17mrnaandadam10proteinholdpotentialasbiomarkersfordetectionofearlygastriccancer
AT jooholee adisintegrinandmetallopeptidasedomainadam12adam17mrnaandadam10proteinholdpotentialasbiomarkersfordetectionofearlygastriccancer
AT kyubumkwack adisintegrinandmetallopeptidasedomainadam12adam17mrnaandadam10proteinholdpotentialasbiomarkersfordetectionofearlygastriccancer
AT sanggyunkim adisintegrinandmetallopeptidasedomainadam12adam17mrnaandadam10proteinholdpotentialasbiomarkersfordetectionofearlygastriccancer
AT sangwoonchoi adisintegrinandmetallopeptidasedomainadam12adam17mrnaandadam10proteinholdpotentialasbiomarkersfordetectionofearlygastriccancer
AT sooyeonoh disintegrinandmetallopeptidasedomainadam12adam17mrnaandadam10proteinholdpotentialasbiomarkersfordetectionofearlygastriccancer
AT sangsoolee disintegrinandmetallopeptidasedomainadam12adam17mrnaandadam10proteinholdpotentialasbiomarkersfordetectionofearlygastriccancer
AT hoeyoungjin disintegrinandmetallopeptidasedomainadam12adam17mrnaandadam10proteinholdpotentialasbiomarkersfordetectionofearlygastriccancer
AT seohyeonchoi disintegrinandmetallopeptidasedomainadam12adam17mrnaandadam10proteinholdpotentialasbiomarkersfordetectionofearlygastriccancer
AT choongkeuncha disintegrinandmetallopeptidasedomainadam12adam17mrnaandadam10proteinholdpotentialasbiomarkersfordetectionofearlygastriccancer
AT jooholee disintegrinandmetallopeptidasedomainadam12adam17mrnaandadam10proteinholdpotentialasbiomarkersfordetectionofearlygastriccancer
AT kyubumkwack disintegrinandmetallopeptidasedomainadam12adam17mrnaandadam10proteinholdpotentialasbiomarkersfordetectionofearlygastriccancer
AT sanggyunkim disintegrinandmetallopeptidasedomainadam12adam17mrnaandadam10proteinholdpotentialasbiomarkersfordetectionofearlygastriccancer
AT sangwoonchoi disintegrinandmetallopeptidasedomainadam12adam17mrnaandadam10proteinholdpotentialasbiomarkersfordetectionofearlygastriccancer